Company profile: Pharsight
1.1 - Company Overview
Company description
- Provider of software and scientific consulting services to pharmaceutical and biotechnology companies in the United States, Europe, and internationally, offering products including Phoenix WinNonlin and WinNonMix for statistical analysis and mathematical modeling of pharmacokinetic (PK)/pharmacodynamic data, and Trial Simulator.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pharsight
VintaBio
HQ: United States
Website
- Description: Provider of cell and gene therapy manufacturing services to pharmaceutical and biotechnology organizations to alleviate the viral vector bottleneck. Offerings include GMP manufacturing with integrated supply chain, process development and toxicology materials from cell line to drug product, research vector production, analytical assays for quality control and release, and CMC support for IND and pre-BLA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VintaBio company profile →
Percuro
HQ: Brazil
Website
- Description: Provider of clinical research and health services, committed to the provision of effective treatments in a safe and supportive environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Percuro company profile →
Vertellus
HQ: United States
Website
- Description: Provider of specialty chemical ingredients for pharmaceuticals, personal care, nutrition, and agriculture, with emphasis on green chemistries. #1 global producer of pyridine, picolines, specialty pyridine derivatives, and DEET. Products include small-molecule APIs; biocompatible polyurethane adhesives/sealants for medical devices; nutraceuticals (Vitamin B3, Zinc, Potassium Chloride); sugar- and amino acid-based surfactants; and silicone-free pigment dispersants for mineral UV filters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vertellus company profile →
Absolute Antibody
HQ: United Kingdom
Website
- Description: Provider of engineered and recombinant antibodies and related services for research and diagnostics, using a proprietary transient-transfection manufacturing platform to produce sequenced and engineered antibodies (AbsoluteAbs). Offerings include antibody sequencing, engineering and expression, primary antibodies, and recombinant antibodies against allergens, coronaviruses (including SARS-CoV-2), viruses, and DNA/RNA targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Absolute Antibody company profile →
Astoriom
HQ: United Kingdom
Website
- Description: Provider of ICH-compliant sample stability and biorepository storage solutions for pharmaceutical and medical device sectors, offering controlled temperature/humidity from -196°C to +60°C with cGMP compliance, packaging and transport; custom storage design; equipment service and validation; disaster protection and recovery; and inventory intelligence with real-time reporting and audit trails.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Astoriom company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pharsight
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pharsight
2.2 - Growth funds investing in similar companies to Pharsight
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pharsight
4.2 - Public trading comparable groups for Pharsight
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →